KOMBINATION EINES UROLITHINS MIT EINER IMMUNOTHERAPIEBEHANDLUNG
European patent · EP4017487 · In force
Register entry
- Publication number
- EP4017487
- Application number
- EP20756907
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Aug 20, 2020
- Published
- Jun 29, 2022
- Granted
- Feb 18, 2026
- Protection ends at the latest
- Aug 19, 2040
- Next annual fee due
- Aug 31, 2027
- IPC classes
- A61K 31/37 (2006.01)A61K 45/06 (2006.01)A61P 31/04 (2006.01)A61P 31/10 (2006.01)A61P 31/12 (2006.01)A61P 33/00 (2006.01)A61P 35/00 (2006.01)A61K 39/395 (2006.01)C07K 16/28 (2006.01)
- Priority
- GB 201912107 22.08.2019
- PCT application
- PCT/EP2020/073436 20.08.2020
- PCT publication
- WO2021/032861 25.02.2021
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Sep 1, 2026
Next annual fee due on
- Next annual fee due on
- 31.08.2026 → 31.08.2027
Published in Swissreg on 01.09.2026
- Mar 25, 2026
Agent entered
- Representative
- RENTSCH PARTNER AG, Kirchenweg 8, Postfach, 8034 Zürich
Published in Swissreg on 25.03.2026
- Feb 18, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 18.02.2026
Parties
Inventor
RINSCH, Christopher
1110 Morges
GRETEN, Florian
61352 Bad Homburg, DE
DRACHSLER, Moritz
60318 Frankfurt am Main, DE
ZIEGLER, Paul
60528 Frankfurt am Main, DE
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.